세계의 바디 컨투어링 디바이스 시장(2024-2031년)

Body Contouring Devices Market Size, Share & Trends Analysis Report by Product Type (Non-invasive and Minimally Invasive Devices, and Invasive Devices), by Application (Nonsurgical skin Resurfacing, Nonsurgical skin tightening, Cellulite treatment, Liposuction, and Others), and by End User (Hospitals, Clinics, and Other), Forecast Period (2024-2031)

Body contouring devices market is anticipated to grow at a CAGR of 14.3% during the forecast period (2024-2031). The body contouring devices market is influenced by factors such as rising obesity rates, technological advancements, aesthetic procedures, minimally invasive treatments, aging population, cultural influences, and regulatory standards. Technological advancements and aesthetic procedures cater to this demand, while cultural attitudes and regulatory compliance ensure the safety and efficacy of these treatments.

Market Dynamics

Increasing Obesity Rates

The demand for body contouring procedures to eliminate extra fat and improve body shape has increased owing to the rise in obesity rates globally. According to the World Health Organisation, in 2022, 1 in 8 individuals globally will be obese, with 2.5 billion adults and 16.0% of children overweight. Over 390 million children and adolescents were overweight, including 160 million living with obesity.

Increasing Aesthetic Consciousness

The demand for body contouring procedures is increasing across all age groups owing to increased aesthetic consciousness and desire for a toned physique, which is driven by social media, celebrity influence, and cultural trends. According to the National Centre for Biotechnology Information, in April 2022, minimally and non-invasive facial aesthetic procedures will see a significant rise in popularity globally. In 2020, approximately 90.0% of the 15.6 million cosmetic procedures performed by plastic surgeons were minimally invasive, such as botulinum toxin or soft tissue filler injections and chemical peels. These procedures contributed to an estimated $16.7 billion spent on aesthetic treatments in the US. Furthermore, the medical aesthetic market is projected to reach a value of nearly $125.0 billion by 2028. According to a recent survey conducted by the American Society of Dermatologic Surgery in 2019, approximately 70.0% of consumers expressed interest in cosmetic procedures, aiming to enhance their confidence and achieve a more youthful and attractive appearance.

Market Segmentation

• Based on product type, the market is segmented into non-invasive and minimally invasive devices and invasive devices.
• Based on application, the market is segmented into nonsurgical skin resurfacing, nonsurgical skin tightening, cellulite treatment, liposuction, and others (fat reduction).
• Based on end-user, the market is segmented into hospitals, clinics, and others (ambulatory surgical centers, and medical spas).

Non-invasive and Minimally Invasive Devices is Projected to Emerge as the Largest Segment

Technological advancements in nonsurgical skin tightening devices have resulted in improved treatment outcomes, shorter treatment durations, and increased patient comfort, leading to a higher rate of acceptance and usage. According to the American Society of Plastic Surgeons, in 2022, the demand for minimally invasive procedures has significantly increased, with a 253% rise since 2019. These treatments offer immediate results, little downtime, and are more cost-effective, with an average surgeon's cost ranging from $530 to $1,800. However, as some individuals face tighter budgets, there has been a recent surge in the popularity of surgical procedures, which offer longer-lasting results but come with a higher price tag, with surgeon's fees typically ranging from $3,000 to $10,000.

Nonsurgical Skin Tightening Segment to Hold a Considerable Market Size

Increased disposable incomes globally drive increased investment in cosmetic procedures, including nonsurgical skin tightening, resulting in a projected growth in demand for these treatments. For instance, in September 2020, Lumenis Ltd. introduced the NuEra Tight with FocalRF technology, a personalized solution for fat reduction, skin tightening, cellulite reduction, and wrinkle reduction. The device offers advanced tools for aesthetic patients, accounting for clinical indications and specific body areas. Its interface features NuAPIC for therapeutic temperature control and NuLogic for protocol customization.

Regional Outlook

The body contouring devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Growth of the Medical Tourism Industry in Asia-Pacific Region

The market for body contouring devices is growing owing to medical tourism, as nations invest in advanced technology to generate foreign patients seeking cosmetic procedures. According to Invest India, healthcare is rapidly evolving globally owing to emerging technologies, economic trends, and consumerism. This has led to a surge in the medical tourism market, which can help achieve universal health coverage by providing access to high-quality services at lower costs. The market, worth $60.0-80.0 billion, sees 14 million people travel for medical tourism.

North America Holds Major Market Share

The rising rates of obesity and healthcare costs in the area, in addition to increasing demand for minimally invasive procedures, are expected to drive market expansion. According to the American Society of Plastic Surgeons, in 2022, the American Society of Plastic Surgeons (ASPS) released the results of their procedural research, conducted in partnership with CosmetAssure and PatientNow. The data revealed that there were 26.2 million surgical and minimally invasive cosmetic and reconstructive procedures performed in the US. Notably, there has been a 19.0% increase in cosmetic surgery procedures since 2019.

The major companies serving the body contouring devices market such as AbbVie Inc., BTL Group, Cutera, Inc., Cynosure, LLC, and Inmode Group, among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. For instance, in January 2024, Cynosure and Hahn & Company merged to form a global leader in medical aesthetic systems. The merger offered a diversified product portfolio, clinical training, research capabilities, a global presence, and a reinforced supply chain, with a presence in over 130 countries.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Market Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. AbbVie Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. BTL Group of Companies
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Cutera, Inc.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Body Contouring Devices Market by Product Type
  • 4.1.1. Non-invasive and Minimally Invasive Devices
  • 4.1.2. Invasive Devices
• 4.2. Global Body Contouring Devices Market by Application
  • 4.2.1. Nonsurgical Skin Resurfacing
  • 4.2.2. Nonsurgical Skin Tightening
  • 4.2.3. Cellulite Treatment
  • 4.2.4. Liposuction
  • 4.2.5. Others (Fat Reduction)
• 4.3. Global Body Contouring Devices Market by End-user
  • 4.3.1. Hospitals
  • 4.3.2. Clinics
  • 4.3.3. Other (Ambulatory Surgical Centers, and Medical Spa)

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East and Africa

6. Company Profiles

• 6.1. Alma Lasers Ltd.
• 6.2. Bausch Health Companies Inc.
• 6.3. Candela Corporation
• 6.4. Cynosure, LLC
• 6.5. ENDYMED
• 6.6. Fotona
• 6.7. InMode Group
• 6.8. LipoTrue, SL
• 6.9. LPG SYSTEMS
• 6.10. Lumenis Be Ltd.
• 6.11. Lutronic Corporation
• 6.12. Merz Pharma GmbH & Co. KGaA
• 6.13. Sciton
• 6.14. SharpLight Technologies Inc.
• 6.15. Sientra, Inc.
• 6.16. Sofwave Ltd.
• 6.17. ThermiGen, LLC.
• 6.18. Zimmer MedizinSysteme GmbH